Isanaka Sheila, Kodish Stephen R, Mamaty Abdoul Aziz, Guindo Ousmane, Zeilani Mamane, Grais Rebecca F
1Epicentre, 8 rue Saint Sabin, 75011 Paris, France.
2Harvard T.H. Chan School of Public Health, 665 Huntington Ave, Boston, MA 02115 USA.
BMC Nutr. 2019 Jul 1;5:34. doi: 10.1186/s40795-019-0298-3. eCollection 2019.
In food insecure settings, it may be difficult for pregnant women to meet increased nutritional needs through traditional diets. A promising new strategy to fill nutrient gaps in pregnancy involves the provision of lipid-based nutrient supplements (LNS). We aimed to assess the acceptability and utilization of a 40 g LNS formulation (Epi-E) with increased micronutrient content relative to the recommended daily allowance among pregnant women in rural Niger.
We conducted a two-part, multi-methods study among pregnant women presenting to antenatal care in Madarounfa, Niger during two periods (Ramadan and non-Ramadan). Part 1 included two LNS test meals provided at the health center, and Part 2 included a 14-day home trial to simulate more realistic conditions outside of the health center. Open- and closed-ended questions were used to assess organoleptic properties of Epi-E using a 5-point hedonic scale after the test meals, as well as utilization and willingness to pay for Epi-E after the 14-day home trial.
Participants consumed more than 90% of the test meal in both periods. Epi-E was rated highly in terms of overall liking, color, taste and smell during test meals in both periods (median 5/5 for all); only time, mode and frequency of consumption varied between Ramadan and non-Ramadan periods in observance of daily fasting during the holy month.
Epi- E, a 40 g LNS formulation with increased micronutrient content, was highly acceptable among pregnant women in rural Niger, and utilization was guided by household and individual considerations that varied by time period. This formulation can be further tested as a potential strategy to improve the nutritional status of pregnant women in this context.
ClinicalTrials.gov Identifier: NCT02145000. Registered 22 May 2014.
在粮食不安全地区，孕妇可能难以通过传统饮食满足增加的营养需求。一种有前景的填补孕期营养缺口的新策略是提供基于脂质的营养补充剂（LNS）。我们旨在评估一种40克的LNS制剂（Epi-E）在尼日尔农村孕妇中的可接受性和利用率，该制剂相对于推荐每日摄入量增加了微量营养素含量。
我们在尼日尔马达鲁恩法的两个时期（斋月和非斋月）对前来接受产前护理的孕妇进行了一项两部分的多方法研究。第1部分包括在健康中心提供的两份LNS测试餐，第2部分包括为期14天的家庭试验，以模拟健康中心以外更现实的情况。在测试餐后，使用开放式和封闭式问题，通过5分喜好量表评估Epi-E的感官特性，在为期14天的家庭试验后评估Epi-E的利用率和支付意愿。
在两个时期，参与者均食用了超过90%的测试餐。在两个时期的测试餐期间，Epi-E在总体喜好、颜色、味道和气味方面的评分都很高（所有方面的中位数均为5/5）；在斋月期间，仅食用时间、方式和频率因遵守每日禁食而在斋月和非斋月期间有所不同。
Epi-E是一种40克的LNS制剂，微量营养素含量增加，在尼日尔农村孕妇中高度可接受，其使用受家庭和个人因素的指导，这些因素因时期而异。在这种情况下，这种制剂可作为改善孕妇营养状况的潜在策略进行进一步测试。
ClinicalTrials.gov标识符：NCT02145000。2014年5月22日注册。
